Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Lilly Expands Migraine Franchise With Reyvow Approval
Oct 11 2019
•
By
Joseph Haas
With approval of Reyvow, Lilly has two approved migraine therapies
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip